November 19, 2020
FDA authorizes first home test for COVID-19
Editor's Note
The Food and Drug Administration (FDA) on November 17 issued an emergency use authorization for the first rapid COVID-19 self-test that a person can administer at home.
The Lucira COVID-19 All-In-One Test Kit has to be prescribed by a healthcare provider, and the healthcare provider has to report the results to public health authorities. The home test is for those 14 years of age or older.
The test also can be used in patient care settings, with nasal swab specimens collected by the provider in those under age 14.
Free Daily News
- Trump vs. Harris: Key differences in healthcare proposals for Medicaid, Medicare, private insurance, abortion
- Updated AAMI standard addresses chemical sterilization safety, compliance
- Study: Stool tests show promise in reducing colonoscopies for post-polypectomy colorectal cancer surveillance
- Healthcare employment up in October
- Save the date for OR Manager Conference 2025
- Session: Staff resilience during extended downtime
- Session: Managing difficult conversations—How to respond effectively to your team
- Closing Keynote: The fire within—The art of bold self leadership
- Session: The case for disrupting, revolutionizing OR, SPD education
- Session: What talented nurses want from potential employers
© Access Intelligence, LLC. All rights reserved. |
Privacy Policy |
Cookie Settings |
Diversity, Equity, Inclusion & Belonging |
Accessibility Statement